LYELL IMMUNOPHARMA INC

Q2 2026 13F Holders

Symbol
LYEL
CUSIP
55083R203
Type
Equity
Class
COM NEW
Num filings
90
Total reported value, excl. options
$168 M
Manager Report Date Value ($000) Shares Option Type